RecruitingPhase 2NCT06326190
177Lu-DOTATATE for Recurrent Meningioma
Studying Meningioma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Prof. Nathalie AlbertEORTC Study Coordinator
- Intervention
- Local standard of Care(drug)
- Enrollment
- 136 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (12)
- A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck, Austria
- Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken, Vienna, Austria
- Centre Leon Berard, Lyon, France
- Centre Eugene Marquis, Rennes, France
- CHRU de Nancy - Hopitaux De Brabois, Vandœuvre-lès-Nancy, France
- Gustave Roussy, Villejuif, France
- Oslo University Hospital - Radiumhospitalet, Oslo, Norway
- St Olavs University Hospital - St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
- Vall D Hebron - Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia, Barcelona, Spain
- Hospital Universitario 12 De Octubre, Madrid, Spain
- Oncology Institute of Southern Switzerland (IOSI) - Ospedale San Giovanni, Bellinzona, Switzerland
- UniversitaetsSpital Zurich - Neurology Clinic, Zurich, Switzerland
Collaborators
Novartis
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06326190 on ClinicalTrials.govOther trials for Meningioma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07413796Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted SuturesMedical University of Warsaw
- RECRUITINGPHASE2NCT06955169Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior TreatmentRTOG Foundation, Inc.
- RECRUITINGPHASE1, PHASE2NCT07150806RYZ101 for the Treatment of Progressive or Recurrent Intracranial MeningiomaJoshua Palmer
- RECRUITINGNANCT06831461Proton Versus Photon Radiotherapy in Adults With Primary Brain TumorsTata Memorial Centre
- RECRUITINGNCT07044076Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With MeningiomasCentre Hospitalier St Anne
- RECRUITINGPHASE2NCT05940493Abemaciclib in Newly Diagnosed Meningioma PatientsNader Sanai
- RECRUITINGNCT06874426The Impact of Endoscopic Endonasal Skull Base Surgery on OlfactionUniversitaire Ziekenhuizen KU Leuven
- RECRUITINGPHASE2NCT06132685Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS TrialEmory University